Cargando…

Reproducibility of Ceftolozane/Tazobactam MIC Results for Enterobacteriaceae and Pseudomonas aeruginosa Using MicroScan Dried Gram-negative MIC Panels

BACKGROUND: A multicenter study was performed to evaluate the reproducibility of Ceftolozane/Tazobactam on a MicroScan Dried Gram Negative MIC (MSDGN) Panel. METHODS: MSDGN panels were evaluated for reproducibility at three sites. For reproducibility, a total of 17 on-scale organisms were tested on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harrington, Amanda, DesJarlais, Sharon, Humphries, Romney, Hindler, Janet, Traczewski, Maria, Beasley, Denise, Brookman, Regina, Chau, Jennifer, Carpenter, Darcie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631329/ http://dx.doi.org/10.1093/ofid/ofx163.1557

Ejemplares similares

Reproducibility of Ceftazidime/Avibactam MIC Results for Enterobacteriaceae and Pseudomonas aeruginosa Using MicroScan Dried Gram Negative MIC Panels
por: Humphries, Romney, et al.
Publicado: (2017)

2132. Multicenter Evaluation of Eravacycline MIC Results for Enterobacteriaceae Using MicroScan Dried Gram-Negative MIC Panels
por: Traczewski, Maria M, et al.
Publicado: (2019)

2131. Multicenter Evaluation of Meropenem/Vaborbactam MIC Results for Enterobacteriaceae Using MicroScan Dried Gram-Negative MIC Panels
por: Garner, Omai, et al.
Publicado: (2019)

342. Multicenter Evaluation of Fosfomycin MIC Results for Enterobacterales Using EUCAST V11 Breakpoints (i.v. and oral for uncomplicated UTI only, E. coli) on MicroScan Dried Gram Negative MIC Panels
por: Garner, Omai, et al.
Publicado: (2022)

667. Multicenter Assessment of Enterobacterales, Salmonella spp. and Pseudomonas aeruginosa Using Updated CLSI Levofloxacin Breakpoints on MicroScan Dried Gram Negative MIC Panels
por: Garner, Omai, et al.
Publicado: (2020)

673. Updated CLSI Ciprofloxacin Breakpoints from a Multicenter Assessment for Enterobacterales, Salmonella spp. and Pseudomonas aeruginosa Using MicroScan Dried Gram Negative MIC Panels
por: Traczewski, Maria M, et al.
Publicado: (2020)

230. Multicenter Assessment of the Accuracy of MIC Results for Colistin with MicroScan Dried Gram Negative MIC Panels using CLSI Breakpoints
por: Riedel, Stefan, et al.
Publicado: (2022)

520. Development of Cefepime-taniborbactam MIC Antimicrobial Susceptibility Test (AST) for Enterobacterales and Pseudomonas aeruginosa on MicroScan Dried Gram-negative MIC Panels
por: Fernandez, Enrique J, et al.
Publicado: (2022)

2060. Comparison of Plazomicin MIC Test Strip and Broth Microdilution MIC Results for 125 Enterobacteriaceae
por: Koeth, Laura, et al.
Publicado: (2018)

Ceftolozane/tazobactam for pulmonary exacerbation in a 63-year-old cystic fibrosis patient with renal insufficiency and an elevated MIC to Pseudomonas aeruginosa
por: Romano, Meredith Tate, et al.
Publicado: (2020)

MIC1 and MIC3: partners in invasion
por: Van Epps, Heather L.
Publicado: (2005)

2166. Performance Study on the New ETEST® Piperacillin/Tazobactam (P/T) MIC Strip
por: Martelin, Roland, et al.
Publicado: (2019)

Determination of MIC Quality Control Parameters for Exebacase, a Novel Lysin with Antistaphylococcal Activity
por: Traczewski, Maria M., et al.
Publicado: (2021)

Open mic
por: CERN. Geneva
Publicado: (2015)

"Open mic"
por: CERN. Geneva
Publicado: (2014)

Open mic
por: CERN. Geneva
Publicado: (2016)

Open mic'
por: CERN. Geneva
Publicado: (2021)

Open mic
por: Henschel, Jack
Publicado: (2022)

Open mic'
por: CERN. Geneva
Publicado: (2022)

2812. Clinical Impact of the Ceftolozane-Tazobactam Shortage on Difficult-To-Treat Resistant Pseudomonas aeruginosa Infections at an Academic Medical Center
por: Vance, Mary K, et al.
Publicado: (2023)

Ceftolozane-tazobactam in nosocomial pneumonia
por: Candel, Francisco Javier, et al.
Publicado: (2022)

473 Comparison of MicroScan System Prompt and Turbidity Methods for Measuring Vancomycin Minimum inhibitory concentration (MIC) against Methicillin-resistant Staphylococcus aureus (MRSA) with MIC of 2ug/ml, the Clinical Implications and economic impact of using alternative antimicrobial agents to vancomycin for MRSA with possible MIC of 2ug/ml
por: Kamran, Amir, et al.
Publicado: (2014)

2439. Outcomes of Minocycline Use on Gram-Negative Infections and Implications of MIC
por: Cheng, Jennifer, et al.
Publicado: (2018)

Performance evaluation of the UMIC(®) Cefiderocol to determine MIC in Gram-negative bacteria
por: Dortet, Laurent, et al.
Publicado: (2023)

Open mic / Announcements
por: CERN. Geneva
Publicado: (2015)

260 Ceftolozane/Tazobactam for the Treatment of cUTI and cIAI Caused by ESBL-producing Enterobacteriaceae
por: Popejoy, Myra, et al.
Publicado: (2014)

1592. In Vitro Activity of Ceftolozane/Tazobactam (C/T) Against Enterobacteriaceae and Pseudomonas aeruginosa Circulating in Chile
por: Rivas, Lina M, et al.
Publicado: (2019)

“Mix of Mics”- Phenotypic and Biological Heterogeneity of “Multipotent” Muscle Interstitial Cells (MICs)
por: Malecova, Barbora, et al.
Publicado: (2012)

Structural insights into crista junction formation by the Mic60-Mic19 complex
por: Bock-Bierbaum, Tobias, et al.
Publicado: (2022)

Higher MICs (>2 mg/L) Predict 30-Day Mortality in Patients With Lower Respiratory Tract Infections Caused by Multidrug- and Extensively Drug-Resistant Pseudomonas aeruginosa Treated With Ceftolozane/Tazobactam
por: Rodríguez-Núñez, Olga, et al.
Publicado: (2019)

In Vitro Activity of Ceftolozane/Tazobactam vs Nonfermenting, Gram-Negative Cystic Fibrosis Isolates
por: Forrester, Jeanne B, et al.
Publicado: (2018)

MIC26 and MIC27 cooperate to regulate cardiolipin levels and the landscape of OXPHOS complexes
por: Anand, Ruchika, et al.
Publicado: (2020)

Structural insights into MIC2 recognition by MIC2-associated protein in Toxoplasma gondii
por: Zhang, Su, et al.
Publicado: (2023)

Erratum: Ceftolozane-tazobactam in nosocomial pneumonia
por: FJ, Candel, et al.
Publicado: (2022)

668. Presence of the Narrow-Spectrum OXA-1 Beta-Lactamase Enzyme is not Associated with Elevated Ceftolozane-Tazobactam MIC Values among ESBL-Producing Escherichia coli Clinical Isolates (CANWARD, 2011-2018)
por: Walkty, Andrew, et al.
Publicado: (2022)

Polymyxin B Etest Fails to Distinguish Carbapenem-resistant Enterobacteriaceae with Elevated Polymyxin B MICs
por: Kulengowski, Brandon, et al.
Publicado: (2017)

124. Impact of Levofloxacin MIC on Outcomes with Levofloxacin Step-down Therapy in Enterobacteriaceae Bloodstream Infections
por: White, Melissa, et al.
Publicado: (2019)

LiF Reduces MICs of Antibiotics against Clinical Isolates of Gram-Positive and Gram-Negative Bacteria
por: Syed, H. C., et al.
Publicado: (2012)

IEEE NSS MIC 2021
por: Tomita, Hideki, et al.
Publicado: (2021)

2384. Multidrug-Resistant Gram-Negative Infections Treated With Ceftolozane–Tazobactam: Impact of Delayed Initiation
por: Jorgensen, Sarah, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ma9pmdsb39e1dgc13kdc2kq6sk